Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2007 R21 RFA-CA-07-002 KAUFMAN, DAVID G. UNIV OF NORTH CAROLINA CHAPEL HILL IDENTIFICATION OF AREAS OF OXIDATIVE DAMAGE IN HUMAN GENOMIC DNA Complete
2007 R21 RFA-CA-07-002 COOPER, LAURENCE J.N. UT MD ANDERSON CANCER CTR UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY Complete
2020 R21 RFA-CA-19-019 LIANG, FU-SEN CASE WESTERN RESERVE UNIVERSITY Spatiotemporal Epitranscriptome Editing Technology Active
2006 R21 RFA-CA-06-004 O'LEARY, TIMOTHY J. AMERICAN REGISTRY OF PATHOLOGY, INC. RECOVERY OF RNA FROM FORMALIN-FIXED TISSUES Complete
2009 R21 RFA-CA-08-006 WIRTZ, DENIS JOHNS HOPKINS UNIVERSITY HIGH-THROUGHPUT INTRACELLULAR MICRORHEOLOGY: A NEW TOOL FOR CANCER RESEARCH Complete
2016 R21 RFA-CA-15-002 MATOUSCHEK, ANDREAS UNIVERSITY OF TEXAS, AUSTIN DEVELOPMENT OF PROTEASOME ADAPTORS TO CATALYTICALLY DEPLETE SPECIFIC PROTEINS FROM CELLS Complete
2000 R21 PAR-99-100 FORTINA, PAOLO M CHILDREN'S HOSPITAL OF PHILADELPHIA FOUR COLOR ARRAY BOUND SNP/MUTATION DETECTION IN CANCER Complete
2008 R21 RFA-CA-07-037 YANNELLI, JOHN R. UNIVERSITY OF KENTUCKY CRYOPREPARATION OF PBMC FOR IMMUNOTHERAPY AND IMMUNE ASSESSMENT STUDIES. Complete
2011 R21 RFA-CA-10-005 RAO, JIANGHONG STANFORD UNIVERSITY NANOTECHNOLOGY FOR MULTIPLEX DETECTION OF ENZYMES Complete
2018 R21 RFA-CA-17-012 SKARDAL, ALEKSANDER (contact); STROWD, ROY ERVIN WAKE FOREST UNIVERSITY HEALTH SCIENCES Predicting Tumor Heterogeneity Evolution After Therapy In Patient-Derived Ex Vivo Glioblastoma Organoids Complete
1999 R21 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
2007 R21 RFA-CA-07-002 KERR, WILLIAM GARROW H. LEE MOFFITT CANCER CTR & RES INST DEFINING THE MULTIPLE MYELOMA KINOME Complete
2017 R21 RFA-CA-16-001 WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Single-molecule counting of cancer biomarker miRNAs in human biofluids Complete
2006 R21 RFA-CA-06-004 JU, JINGFANG UNIVERSITY OF SOUTH ALABAMA NOVEL METHOD FOR ISOLATING ACTIVELY TRANSLATED MRNAS Complete
2009 R21 RFA-CA-08-006 KANDEL, EUGENE S ROSWELL PARK CANCER INSTITUTE CORP ARRAY-ASSISTED INSERTIONAL MUTAGENESIS FOR MOLECULAR ANALYSIS OF CANCER Complete
2013 R21 RFA-CA-12-002 LU, CHANG VIRGINIA POLYTECHNIC INST AND ST UNIV SENSITIVE AND INTEGRATED MICROFLUIDIC CHIP ASSAYS FOR STUDYING TRANSCRIPTIONAL RE Complete
2016 R21 RFA-CA-15-002 RECHT, MICHAEL PALO ALTO RESEARCH CENTER HIGH-THROUGHPUT SCREENING PLATFORM FOR CANCER DRUG DISCOVERY Complete
2000 R21 PAR-99-100 STANTON, MARTIN J BRANDEIS UNIVERSITY APTAMER BASED DETECTOR TO QUANTIFY MACROMOLECULES Complete
2008 R21 RFA-CA-07-037 WEIER, HEINZ-ULRICH GUENTER UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB ACCELERATING CANCER RESEARCH WITH SINGLE CELL ARRAYS Complete
2011 R21 RFA-CA-10-005 LAWRENCE, DAVID A WADSWORTH CENTER HOLISTIC DIAGNOSTICS OF HOST DURING DEVELOPMENT OF CANCER Complete
1999 R21 PAR-98-067 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES ULTRA-SENSITIVE APPROACH FOR MONITORING GENE PRODUCTION Complete

Pages